Clinical Trial Update: A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase I trial evaluating high-dose intravenous ascorbate (vitamin C) in patients with glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Ascorbate (ascorbate)

Snippet

Sponsor: Joseph J. Cullen, MD, FACS | Conditions: Glioblastoma, GBM | Phase 1 | Status: COMPLETED